In this guest commentary, Caleb Appleton, a principal at Bison Ventures, offers up a framework biotech founders can use to determine whether they should market their platform to others, or leverage it ...
Eli Lilly is making a play for the idiopathic pulmonary fibrosis (IPF) market, offering Mediar Therapeutics $99 million in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback